ABSTRACT
Introduction
We have previously reported that the hydroalcoholic crude extract from Casearia sylvestris Sw. (HCE-CS) exert several actions on specific responses of pain and inflammation. Antinociceptive actions were evident in animal models of nociceptive, inflammatory and immune mediated pain (De Mattos et al., 2007) ; furthermore, the HCE-CS was also endowed with anti-inflammatory properties in the model of carrageenan-paw edema in mice, as well as in pleurisy model in rats reducing neutrophil recruitment and nitrite/nitrate production in pleural exsudate (Albano et al., 2013) .
The Casearia sylvestris specie was recently related to the family of Salicaceae (Ferreira et al., 2011) and contains phytochemicals from different classes of medicinal interest such as sesqui- (Bou et al., 2013) and diterpenes (Meesakul et al., 2016) .
Among this last class, Dos Santos and colleagues (Dos Santos et al., 2010) recently reported the isolation of five new compounds, termed casearins and casearvestrins.
Together with other coumpounds, casearins can be able to inhibit the activity of phospholipase A 2 (PLA 2 ) (Borges et al., 2000; Borges et al., 2001) , which seems to be a property in agreement with the ethnopharmacological use of the plant in popular medicine for the treatment of wounds and ulcers or against snake bites (Ferreira et al., 2011) . Collectively, these results raise the possibility that the plant could exert antinociceptive and anti-inflammatory effects based on mechanisms relied on resolution of inflammation pathways in other unexplored models of pain and inflammation, since PLA 2 is also targeted by others pro-resolving mediators.
The resolution of inflammation is a programmed response from the organism to enable the end of the inflammatory process and ensure that the affected organ goes back to its pre-inflammatory settings and function (Perretti, 2015) . Specific pro-resolving mediators and pathways are operative to enact resolution including those centred on annexin A1 (AnxA1) and lipoxin A4 (LXA4) (Cash et al., 2014) . Accumulating evidence from diverse animal models indicate modulatory properties for pro-resolving mediators on nociception (Pei et al., 2011; Pierretti et al., 2001 ) and hyperalgesia (Abdelmoaty et al., 2013; Hu et al., 2012; Huang et al., 2011) , through mechanisms that involve modulation of the expression of transcriptional factors and cytokines (Liu et al., 2016; Sun et al., 2012; Wang et al., 2014) . Similarly, pivotal roles for the endogenous local signals that govern resolution to impact on pain processes have already defined (for review : Serhan, 2008) . Against this background, we speculated a possible synergism of action for both HCE-CS and pro-resolving mediators on pain associated with inflammatory processes, the main example here being chronic post-ischemic pain (CPIP) typical of the Complex Regional Pain Syndrome-Type I (CRPS-I). CRPS-I model is able to faithfully reproduce many of the symptoms related to this syndrome in humans such as hyperalgesia, edema, vasomotor dysfunction and trophic changes (Laferrière et al., 2008) . Using this model, after induction of ischemia and reperfusion (I/R) in the hindpaw of animals, is possible to evaluate an initial phase of paw edema and inflammatory pain (up to 3 days after reperfusion) followed by a form of neuropatic pain (from 7 to 21 days after reperfusion) (Martins et al., 2013; Millecamps et al., 2010) . Studies have elucidated few aspects of the histology of the skin and microvasculature of the paw tissues after I/R (Coderre & Bennett, 2010; Millecamps, 2010 ), yet joints and skeletal muscle have not been investigated, both in the absence or presence of specific pharmacological treatments. Herein, we aimed to investigate the effect of HCE-CS or pro-resolving mediators on mechanical hyperalgesia observed in CRPS-I through behavioral and histological analysis, as well as establish a possible influence of resolution of inflammation pathways to the effects of the plant extract.
Material and methods

Preparation and characterization of the hydroalcoholic crude extract of Casearia sylvestris (HCE-CS).
Extract was obtained from leaves of the plant collected at the botanical Horto at the campus of University Southern Santa Catarina (UNISUL), in the municipality of Tubarão, Santa Catarina, Brazil (latitude 28º28'00" south and longitude 49º00'25" west) and prepared as previously described (Albano et al., 2013) and the plant was identified by direct comparison with a voucher specimen (SRS-174) deposited at the herbarium Laelia Purpurata (SRS) at this university. Concentrated HCE of Casearia sylvestris was then stored in a desiccator until the moment of use.
The HCE-CS was analyzed by ultra-high performance liquid chromatography coupled to diode array detection (UHPLC-DAD) using water (A) and acetonitrile (B) as eluents and a solid core C18 chromatographic column (Kinetex C18, 150 x 2.1 mm, 2.6 μm, 100 Å) according to the method previously developed (Bueo et al., 2015) . A volume of 2 μL of each sample and the points of the analytical curve were injected in triplicate under the following elution gradient: 10 to 25% of B for 15 min and then 25 to 90% of B for 20 min, remaining in this condition for 5 min. A method for reconditioning was incorporated so that it returned to the initial condition in 2 min and remained in that condition for another 3 min, for a total time of 45 min. The flow rate was 0.4 mL/min, with column temperature at 35°C, detection range 200-800 nm and plotting the chromatograms at 235 nm.
Identification of the main compounds was achieved by ultra-high performance liquid chromatography coupled to mass spectrometry in positive mode (UHPLC-ESI-MS, Amazon SL, Bruker Daltonics) with the aid of previously isolated standards and information from literature. The chromatographic conditions were the same as described above. The ion trap operated in enhanced resolution mode with a capillary potential of 140 V. The capillary temperature was set at 300 °C with a nebulizer pressure of 30 psi and a dry gas flow of 8 L min−1.
From an analytical curve based on caseargrewiin F was possible to determine the concentration of total casearins in the HCE-CS. For each sample, the total of casearins content was calculated by summing the areas of all peaks corresponding to this compounds in the chromatograms and expressing the results as a function of caseargrewin F. It is important to note that, for such substances, the spectra in the ultraviolet region have a characteristic peak at 225-235 nm (Fig. 1A) . The total casearins content was 18.6 mg/g (or 1.86% m/m), with a standard deviation of 0.8% (Fig. 1B) . Experimenters were blinded to treatment conditions.
Hindpaw ischemia and reperfusion.
The animal model of CPIP was generated following exposure to prolonged hind paw I/R and was carried out according to the procedure described for rats (Coderre et al., 2004) and adapted for mice (Millecamps et al., 2010) . Mice were anesthetized over a 3 h period with a bolus (7%, 0.6 ml/kg, i.p.) of chloral hydrate and 20% of the initial volume at the end of the first and second hour. After induction of anesthesia, an elastic -ring for races ( l stic o Ligadura 000-1237, Uniden, SP, Brazil) with 1.2 mm internal diameter was placed around the right hind limb just proximal to the ankle joint.
The O-rings were selected to provide a tight-fit that produced ischemia. They were left on the limb for 3 h as initially described with larger O-rings. The O-ring was always positioned at a point on the limb just proximal to the medial malleolus. Sham mice were subjected to the same procedure except that the O-ring was cut so that it only loosely surrounded the ankle and did not occlude blood flow to the right hind paw (Martins et al., 2013) .
2.4. Assessment of mechanical hyperalgesia in Swiss mice.
The characteristic mechanical hyperalgesia of CPIP induced by the I/R procedure was assessed using von Frey monofilaments (VFH, Stoelting, Chicago, USA), measured as the frequency of response (in percentage) of paw withdrawal from the tested animals, to 10 applications of a von Frey filament with a force of 0.6 g. The test was performed using a platform (70 cm x 40 cm), which consists of a wire screen mesh of 6 mm to facilitate the application of the filament on the ventral surface of the hind paw of the animals. Mice were individually placed in an observation chamber made of acrylic (9 cm x 7 cm x 11 cm), which had no bottom and was covered. The following criteria for applying the mechanical stimuli were considered: a) application was made perpendicularly to the plantar surface with sufficient pressure to provide the curvature of the filament, obtaining the total pressure, b) the animals were assessed when all four paws were accommodated on the screen, c) the withdrawal response was considered positive when the animal completely removed its paw from the surface of the screen.
The mechanical hyperalgesia was evaluated before the I/R (basal values) and at different times after treatment. 2.6. Histological Analysis.
Samples obtained from the in vivo experiments were processed according to the type of ex vivo analysis as described below. Since histology for skeletal muscle or joints (cartilage or pannus formation) had never been evaluated during the inflammatory phase of CRPS-I model, the samples of animal paws removed at 49 h after reperfusion.
Samples were embedded in paraffin, cut into microtome sections (5 μm) and mounted on glass slides to assess the tissue changes in animals from different groups after I/R procedure. For muscle investigation, samples were processed for staining and analysis using methodolgy previously described (Norling et al., 2016; Headland et al., 2015) . marginal pannus and invading the synovium). Finally, cartilage erosion was assessed from images encompassing the tarsus-navicular area of the phalangeal-metatarsal joint analysed by using the ImageJ ® software, in which images were divided within the channels of different colours (red, green and blue) and images were selected from the channel that best represented the positive and negative stainning in the samples. A colouring threshold was applied to the image of that channel, tracing the total cartilage area from which the software removed the erosion area (without staining), resulting in the percentage of the remaining cartilage area without erosion.
Characterization of cell types in the inflammatory infiltrate.
Given that the one of the most accentuated phenomen observed during inflammatory phase is the edema (with plasma and cell extravasation from the vessel), histological analyses in the hind paw of the animals subjected to I/R-induced injury also examined the type of inflammatory cell present in the infiltrate, 49 h after paw reperfusion according to techniques previously registered (Leinster et al., 2012) . This evaluation was performed using the immunofluorescence technique with samples of hind paws of animals belonging to different treatment groups, which were embedded in paraffin, cut into microtome sections (5 μm) and mounted on glass slides with subsequent rehydration. Antigen retrieval was performed in citrate buffer (pH 6.0) at 94°C for 30 min, followed by incubation in hydrogen peroxide solution (0.3%) to block endogenous peroxidases. To identify macrophages or lymphocytes in cell infiltrates, samples were incubated overnight with primary antibodies against CD68 (Zymed, 1:100) or CD3 
Statistical analysis
The Shapiro-Wilk test was used to evaluate the normality assumption of behavioral and biochemical data. All variables in the present study showed a normal distribution.
Differences among experimental groups were determined by one or two-way ANOVA followed by Student-Newman-Keuls Multiple Comparison or Bonferroni post hoc Test, respectively, when appropriate. A value of p< 0.05 was considered to be statistically significant. All data are presented as mean + standard error of the mean (SEM).
Results
Influence of pro-resolving mediators in the CRPS-I model
Treatment of the animals with different pro-resolving mediators at 10 min, 24 and 48 h after I/R, reduced the mechanical hyperalgesia quantified in this model (Fig. 2) . At 26 hours after I/R, or 2 h after second treatment, RvD1 (21.7  7.6% frequency of response), 15-epi-LXA4 (22.7  7.3%) and BML-111 (1 µg/animal: 31.4  5.0%) reduced frequency of response to von Frey filaments stimulus when compared to vehicle treated animals (52.7  7.3% frequency of response).
Fig. 2:
Effect of pro-resolving agonists on experimental CRPS-I. Mice were subjected to I/R-induced CRPS-I (see Methods). RvD1 (100 ng, i.v.), 15-epi-lipoxin A4 (1 µg, i.v.) or BML-111 (100 ng to 1 µg, i.v.) were administered at 10 min, 24 and 48 h after reperfusion and mechanical hyperalgesia was quantified up to 72 h after reperfusion. Data are presented as mean ± S.E.M., n=8 (# and *= p< 0.05 vs. sham or vehicle groups, respectively; Two-way ANOVA followed by Tukey's test (A) or One-way ANOVA followed by Bonferroni (B).
WRW4 prevents antihyperalgesic effect of HCE-CS or BML-111 during inflammatory phase of CRPS-I model
We then tested the treatment with HCE-CS which evoked antihyperalgesic effects (30 mg/Kg, p.o., at 10 min, 24 and 48 h after I/R) of similar magnitude to those observed with BML-111 (1 µg/animal, s.c.) or dexamethasone (0.5 mg/Kg, p.o.; Fig. 3 ). Of interest, the anti-hyperalgesic effect of HCE-CS observed at 49 h was reversed by pretreatment of the animals with the antagonist WRW4 (Fig. 4) . ) mice were subjected to I/R-injury (see Methods) and mechanical hyperlagesia was assessed at 49 h after reperfusion. Data are presented as mean ± S.E.M., n=8 (One-way ANOVA followed by Tukey's test). Fig. 7 shows that the main cell type was the neutrophils, while lymphocyte and macrophage cells could not be readily detected in the tissue at this time point, given that no immunofluorescence-staining characteristic for CD3 or CD68 markers, respectively, was observed (data not shown).
Involvement of LXA4-ALX/FPR2 pathway in the anti-hyperalgesic effect for HCE-CS
At 49 h after reperfusion, skeletal muscle of the paw subjected to I/R injury (disease) and neutrophils infiltrated to this tissue, did not express mediator AnxA1 (Fig. 8, Panel A). Besides of this, HCE-CS or BML-111 treatment increased the extent of ALX/FPR2 receptor expression in skeletal muscle and neutrophils in relation to disease group, as determined by immunofluorescence (Fig. 8, Panel B) . In this last experiment, differences between sham and disease animals could not be compared once the architecture of the muscle cells was significantly affected by the disease.
Finally, no pannus formation was detected in the joints of treated animals as compared to the control group (sham). In a similar manner, I/R-induced injury (disease) did not cause cartilage erosion as monitored in a variety of joints in relation to the control group (sham). Both staining with Toluidine Blue (Fig. 9, panel A) or Fast Green + o-Safranin (Fig. 9, panel B) were performed. (1 µg, s.c.) at 10 min, 24 and 48 h after reperfusion. In quantitative analysis data are presented as mean ± S.E.M., n=8 (One-way ANOVA followed by Tukey's test). Fig. 7 . Neutrophils are the main cell type inflitrating the metatarsal region of hind paws during the inflammatory phase of CRPS-I model in mice. Mice were subjected to I/Rinjury and immunfluorescence analysis (Ly6G for neutrophils; see Methods) was conducted in hind paws harvested at 49 h after reperfusion from animals belonging to the sham or disease groups. Quantitative data for ALX/FPR2 are presented as mean ± S.E.M., n=8 (One-way ANOVA followed by Tukey's test). 
Discussion
The present study demonstrated that HCE from the leaves of Casearia sylvestris displayed powerful anti-hyperalgesic effects during the inflammatory phase of experimental CRPS-I. These data also indicate, likely for the first time, an involvement of the mechanisms of the resolution of inflammation in the properties of the plant extract leading to the suggestion that both classes of compounds (HCE-CS and proresolving mediators) can provide pharmacological tools for the treatment of this condition in humans.
CRPS-I is a debilitating disease, with a complex clinical presentation which importantly includes disturbances in sensorial perception leading to severe pain (Coderre & Bennett, 2010) . Our findings that HCE-CS and pro-resolving mediators can reduce mechanical hyperalgesia is particularly important given that both classes of compounds (phytochemicals and pro-resolving lipid mediators) afforded efficacy similar to dexamethasone. While this last substance, from the glucocorticoid class, can be useful in the therapeutic management of CRPS-I, adverse effects are very well documented especially after chronic treatment. On these bases, new phamacological tools that control symptoms during the course of CRPS-I are of need.
With relation to possible mechanisms of action, it seems that this is the first study to evaluate contribution of resolution of inflammation pathways on antihyperalgesic effect exerted by an extract of plant. Chromatographic analysis of HCE-CS used in this study revealed the presence of several casearins including casearin-X, which was already implicated for its capability of coupling to GABA-A comples neuron receptors (de Araújo et al., 2017) , what could influence pain phenomena. In the other hand, our results with the CRPS-I model demonstrate that a selective ALX/FPR2 antagonist (Shin et al., 2006) , WRW4 prevented the antihyperalgesic action for HCE-CS or BML-111 implicating this receptor in modulatory mechanisms on nociception exerted by these treatments during the inflammatory phase of this experimental disease. These data unveil that HCE-CS and BMLL-111-induced overexpression of this receptor occurs locally, both in skeletal muscle and in neutrophils at the site of I/R injured tissue. However, this receptor is also expressed centrally (Abdelmoaty et al., 2013) hence we cannot exclude a priori a role for central ALX/FPR2 in these pharmacoligical effects reported here. Within the periphery, inflitrated neutrophils but not lymphocytes or macrophages could be quantified though the treatments did not alter their values. One could propose that the phenotype of the immune cells could have been changed by the anti-nociceptice treatments of which the higher expression of ALX/FPR2 could be the marker. We note how this receptor is over-expressed following TNF application as well as upon contril by endogenous TNF in sepsis (Gobtti et al., 2014) . In human neutrophils, sex hormones promote an AnxA1+ALX/FPR2 phenotype (Nadkarni et al., 2011) which is associated with vascular protection (Nadkarni et al., 2014) . It remains to be establish here what are the molecular determinants linking the plant extract and BML-111 to ALX/FPR2 overexpression but the functional data indicate a relevant engagement of this receptor in the effects described herein.
We propose that aside mast cells seems to contribute to CRPS-I (Huygen et al., 2004) , is reasonable that neutrophil infiltration to the muscle might have implications to the nociceptive process observed in the present study, with appearing of mechanical hyperalgesia in I/R-induced animal, since in humans decreased pressure pain threshold (muscle hyperalgesia) is one of the most proeminente sensory abnormalities observed (van Rooijen et al., 2013) . Considering the present model of CPIP induced by I/R, these founds are also in agreement with the idea that targeting ALX/FPR2 receptors in both types of cells can be useful to treat symptoms of diseases in which pathophysiology relies importantly on vascular disturbances Dufton & Perretti, 2010) , specially those involving I/R-induced injuries (Gavins, 2010) .
In view of the number of ligands that can interact with ALX/FPR2 receptor, it could be hard to identify the endogenous agonist responsible for the antihyperalgesic effects observed here, though AnxA1 and LXA4 are obvious candidates. However, based on our behavioural experiments as well as on recent published studies, we can indicate LXA4 as the most likely mediator involved in these actions. Firstly, BML-111 is a synthetic analog for LXA4 and it produced biological effects through interaction with the ALX/FPR2 receptor as reported in several systems (Sordi et al., 2013; Wu et al., 2016) . Secondly, LXA4 levels are increased in mice in a model of I/R, specially after reperfusion stage, in which large amounts of neutrophil/platelet aggregates are formed (Brancaleone et al., 2013) . In vitro, LXA4 exerts powerful tissue protective effects on rat cardiomyocites after I/R through up-regulation of heme oxygenase-1 (Chen et al., 2013) , downregulation of GRP-78 and caspase-12, as well as inhibition of cell apoptosis; while in vivo, the mediator was also beneficial to vascular smooth muscle cells in a mouse model of carotid artery ligation . At variance from LXA4, our data exclude presence and functional involvement of AnxA1 since this protein was not particularly abundant at the site of injury and its absence in the knock out mice failed to influence mechanical hyperalgesia. This last result is in agreement with recently published, in which muscles in AnxA1-deficient mice were not affected in size or in repair of myofibers following application of different types of injuries (Leikina et al., 2015) .
Altogether these data allow us to speculate that during the inflammatory phase of a mouse CRPS-I model, ALX/FPR2 expressed in neutrophils and skeletal muscle is targeted by HCE-CS, directly or indirectly through endogenous LXA4 release (an effect mimicked by the pharmacological delivery of BML-111). Engagement of ALX/FPR2 would in turn reduce mechanical hyperalgesia promoted by derangement in this tissue.
Antihyperalgesic effect for LXA4 and its derivatives is very well documented in different animal models (Petri et al., 2015; Wang et al., 2014; Abdelmoaty et al., 2013) .
On other hand HCE-CS has already presented antinociceptive action (De Mattos et al., 2007) and it can also evoke antiinflamatory and antioxidant properties (Albano et al., 2013) .
Finally, regarding our present findings from histological analysis, besides other models of CRPS-I induced by nerve ligation (Li et al., 2013) or auto-immunity (Goebel & Blaes, 2013) have also been described, in the present study we used a model of CRPS-I caused by I/R wich faithfully reproduces human symptoms (Laferrière et al., 2008) . Currently, morphological alterations observed during CRPS-I is not related to nerve injury or bone alterations, specially during initial phases of the disease; however, changes in skin, specially in microcirculation, and muscle tissues have been found (Coderre & Bennett, 2010; Millecamps et al., 2010) . In muscles, patients who have suffered amputation of the affected limb, presented major disturbances such as fatty degeneration, atrophy of fibers and nuclear agglomeration, not related to the duration of the syndrome, while extensor and flexor muscles of the forearm from other patients were affected as evaluated by ultrassonography (Goebel & Blaes, 2013; Vas et al., 2013; Huang et al., 2011; Schürmann et al., 2007) . This results are in accordance with our histological data demonstrating no alterations in cartilage nor pannus formation at the joints of animals from disease group while, in the contrary, skeletal muscle was massively surrounded by infiltration of inflammatory cells which, as expected, were not present in sham group.
Conclusion
We presented evidence that to demonstrate the involvement of a pathway of resolution of inflammation centred on LXA4 and the receptor ALX/FPR2 in the antihyperalgesic effect for HCE-CS and BML-111 during the inflammatory phase of CPIP model. These results also suggest a potential role for endogenous pro-resolving mediators in the pharmacological properties of Casearia sylvestris extract, a conclusion that may have dual implications with respect to innovative therapies for this debilitating conditions: i) use the extract as a novel treatment for CRPS-I in humans and ii) develop ALX/FPR2 agonists, likely modeled on LXA4, as novel scaffold for therapeutic development.
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